Scotiabank analyst Nick Altmann maintained a Hold rating on HashiCorp (HCP – Research Report) today and set a price target of $21.00. The company’s shares closed yesterday at $23.96.
Altmann covers the Technology sector, focusing on stocks such as HashiCorp, HubSpot, and Atlassian. According to TipRanks, Altmann has an average return of 5.8% and a 50.00% success rate on recommended stocks.
Currently, the analyst consensus on HashiCorp is a Moderate Buy with an average price target of $27.15, implying a 13.31% upside from current levels. In a report released today, TD Cowen also maintained a Hold rating on the stock with a $26.00 price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $36.39 and a one-year low of $18.91. Currently, HashiCorp has an average volume of 2.79M.
Based on the recent corporate insider activity of 117 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HCP in relation to earlier this year. Most recently, in December 2023, David McJannet, the CEO & Chairman of HCP sold 217,833.00 shares for a total of $2,451,641.61.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HashiCorp (HCP) Company Description:
HashiCorp Inc is engaged in solving the infrastructure challenges of cloud adoption by enabling an operating model that unlocks the full potential of modern public and private clouds. Its cloud operating model provides consistent workflows and a standardized approach to automate the processes involved in delivering applications in the cloud: infrastructure provisioning, security, networking, and application deployment. Its main commercial products are Terraform, Vault, Consul, and Nomad.
Read More on HCP:
- HashiCorp Announces Fourth Quarter and Fiscal Year 2024 Financial Results
- HCP Upcoming Earnings Report: What to Expect?
- Moderna downgraded, Gap upgraded: Wall Street’s top analyst calls
- HashiCorp upgraded to Overweight from Equal Weight at Morgan Stanley
- HashiCorp to announce fourth quarter and fiscal year 2024 financial results Mar. 5, 2024
